Earnings Per Share
EPS (Diluted)
Merck & Co. EPS (Diluted) decreased by 243.3% to $-1.72 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 185.6%, from $2.01 to $-1.72. Over 3 years (FY 2021 to FY 2025), EPS (Diluted) shows an upward trend with a 12.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionEarnings Per Share
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 4, 2026
How to read this metric
Higher values indicate stronger profitability even when accounting for potential share dilution.
Detailed definition
Calculated by dividing net income by the weighted-average number of common shares outstanding, assuming the conversion o...
Peer comparison
Used by all public companies to provide a realistic view of earnings per share for investors.
Metric ID:
eps_dilutedHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.61 | $1.80 | $1.48 | $1.70 | $1.55 | $1.28 | $1.18 | $1.11 | -$2.35 | $1.86 | $1.87 | $2.14 | $1.24 | $1.48 | $2.01 | $1.76 | $2.32 | $1.20 | -$1.72 |
| QoQ Change | — | +195.1% | -17.8% | +14.9% | -8.8% | -17.4% | -7.8% | -5.9% | -311.7% | +179.1% | +0.5% | +14.4% | -42.1% | +19.4% | +35.8% | -12.4% | +31.8% | -48.3% | -243.3% |
| YoY Change | — | — | — | — | +154.1% | -28.9% | -20.3% | -34.7% | -251.6% | +45.3% | +68.5% | +191.1% | -33.3% | — | +7.5% | -17.8% | +87.1% | -18.9% | -185.6% |
Range-$2.35 – $2.32
CAGR+25.9%
Avg YoY Growth-2.7%
Median YoY Growth-18.3%
Current Streak2 quarters decline
EPS (Diluted) at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s eps (diluted)?
- Merck & Co. (MRK) reported eps (diluted) of $-1.72 in Q1 2026.
- How has Merck & Co.'s eps (diluted) changed year-over-year?
- Merck & Co.'s eps (diluted) decreased by 185.6% year-over-year, from $2.01 to $-1.72.
- What is the long-term trend for Merck & Co.'s eps (diluted)?
- Over 3 years (2021 to 2025), Merck & Co.'s eps (diluted) has grown at a 12.4% compound annual growth rate (CAGR), from $5.14 to $7.29.
- What does eps (diluted) mean?
- Earnings per share calculated as if all potential shares were issued.